Hepatic drug-metabolizing activities in rats after 14 days of oral administration of the human immunodeficiency virus-type 1 protease inhibitor ritonavir (ABT-538).

Google Scholar
  • 1 May 1996
    • journal article
    • Vol. 24 (5), 615-7
Abstract
No abstract available